- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01377064
Home-based Exercise for Management of HIV-associated Cardiovascular Disease Risk
April 27, 2021 updated by: University of South Carolina
Home-based Exercise for Management of HIV-associated Cardiovascular Disease
Because of advances in drug treatment, people living with HIV/AIDS (PLWHA) are living longer, but are also at greater risk for cardiovascular disease (CVD) and diabetes.
Exercise and increased physical activity can reduce the risk factors for these diseases in PLWHA, but no studies have tested an at-home exercise program that would benefit low income people and others who do not have access to exercise facilities.
This study will test the feasibility of an at-home exercise program for PLWHA and prepare for a full-scale intervention study, which may lead to a reduction in CVD risk among PLWHA.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- The Citadel
-
Columbia, South Carolina, United States, 29208
- University of South Carolina
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 18 years and older
- Medical diagnosis of HIV-1 positive serostatus
- Sedentary lifestyle: not actively exercising ≥ 3 d•wk-1 for 20 min per session
- 18.5 kg/m2 < BMI < 40.0 kg/m2
- Stable, DHHS-approved ART regimen for previous 3 months, with HIV viral load below 75 copies/mL
- Capable of performing the required exercise regimen
- Have daily access to a telephone for approximately 10 months
- Capacity and willingness to provide informed consent and accept randomized group assignment
Exclusion Criteria:
- Individuals who have a clinical history strongly suggestive of Type 1 diabetes.
- History of serious arrythmias, cardiomyopathy, congestive heart failure, stroke or transient ischemic cerebral attacks, peripheral vascular disease with intermittent claudication, myocardial infarction, or CABG.
- Malignancies in the past 5 years, except therapeutically controlled skin cancer.
- Plans to be away > 4 weeks in the next 9 months
- Score of 5 or greater on the DAST or MAST (signifying excessive use of drugs or alcohol).
- Weight loss in excess of 10% body weight in previous 12 weeks.
- Chronic or recurrent respiratory, gastrointestinal, neuromuscular, neurological, or psychiatric conditions.
- Inflammatory-related conditions such as collagen disorders.
- Any other medical condition or disease that is life-threatening or that can interfere with or be aggravated by exercise.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Physical activity group
Subjects will participant in physical activity program
|
9 months of home based physical activity meeting HHS recommendations for physical activity for all americans
|
Active Comparator: Standard care group
This group will not receive a physical activity intervention
|
No intervention, the group will be followed under their standard medical care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Amount of Physical Activity
Time Frame: 9 months
|
Accelerometer data will be the primary means of determining the participants' physical activity levels.
Participants will be instructed to wear the accelerometer at baseline, 4 months, and 9 months.
The participants will be required to wear the accelerometer during the waking hours for seven consecutive days.
Data from participants with at least four days and at least 10 hours per day will be included.
|
9 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cardiorespiratory Fitness
Time Frame: 9 months
|
Each participant will complete a graded exercise stress test (GXT) with indirect calorimetry.
This test will be used to screen for abnormal physiological responses to exercise and for determining the participant's maximal ability to utilize oxygen (an index of cardiorespiratory fitness).
|
9 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2011
Primary Completion (Actual)
July 1, 2013
Study Completion (Actual)
July 1, 2013
Study Registration Dates
First Submitted
June 8, 2011
First Submitted That Met QC Criteria
June 16, 2011
First Posted (Estimate)
June 20, 2011
Study Record Updates
Last Update Posted (Actual)
April 28, 2021
Last Update Submitted That Met QC Criteria
April 27, 2021
Last Verified
April 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00007339
- 1R21NR011281 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Medical College of WisconsinRecruitingCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
University of FloridaUniversity of Alabama at Birmingham; Brown UniversityCompletedCardiovascular Disease | Psychosocial Influence on Cardiovascular DiseaseUnited States
-
Nanjing Medical UniversityRecruiting
-
Centre Hospitalier Universitaire de la RéunionRecruitingCardiovascular DiseaseFrance
-
National Heart, Lung, and Blood Institute (NHLBI)RecruitingCardiovascular DiseaseUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)RecruitingCardiovascular DiseaseUnited States
Clinical Trials on Physical Activity Group
-
Centro di Riferimento per l'Epidemiologia e la...Azienda Sanitaria Locale Torino 1CompletedBreast Cancer | Colorectal Cancer | Lifestyle Risk Reduction | Weight Changes, BodyItaly
-
Istanbul University - Cerrahpasa (IUC)Unknown
-
Universidad de CórdobaUnknown
-
University of Nove de JulhoCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.UnknownQuality of Life | PainBrazil
-
Université Sorbonne Paris NordLigue contre le cancer, France; Garmin International; StimulabRecruitingBreast Cancer | Lung Cancer | Prostate Cancer | Colo-rectal CancerFrance
-
St. Louis UniversityWithdrawn
-
Karolinska InstitutetTerminatedOesophageal CancerSweden
-
The Netherlands Cancer InstituteDutch Cancer SocietyUnknownMenopausal Symptoms in Breast Cancer Patients With Treatment-Induced Complaints
-
University of Nove de JulhoUniversity of Sao PauloCompleted
-
Hospital de Clinicas de Porto AlegreFederal University of Rio Grande do Sul; Conselho Nacional de Desenvolvimento...Not yet recruiting